Bio Special BioInvest

BioAge Secures $170 Million in Series D Funding to Propel Obesity and Metabolic Disease Drug Development

  BioAge Labs (“BioAge”), a pioneering biotechnology firm dedicated to advancing novel treatments for obesity and metabolic diseases by e...

 February 14, 2024 | News

BioNTech's $200 Million Investment in Autolus Marks Milestone in Strategic CAR-T Collaboration, Revolutionizing Cancer Therapy

      Strategic alliance leverages manufacturing and commercial infrastructure as well as technology with the aim to advance both...

 February 08, 2024 | News

Novo Nordisk's Investment Arm, Novo Holdings, Seals $16.5 Billion Deal to Acquire Catalent in All-Cash Transaction

Catalent, Inc. (NYSE: CTLT), a prominent player in advancing global patient treatment solutions, and Novo Holdings, a holding and investment entity oversee...

 February 06, 2024 | News

Taiwan's Anbogen Secures $12.5M in Series A for Precision Oncology

The lead investor is China Development Industrial Bank (CDIB), with significant contributions from Taian Venture Capital, Maxpro and the National Developme...

 February 01, 2024 | News

Singapore's GDMC Raises $21M to Boost Global Genetic Therapy Manufacturing

Funding is led by existing investor Celadon Partners with participation from SEEDS Capital, NSG Ventures and WI Harper Group GDMC aims to use the ...

 January 26, 2024 | News

PRISM BioLab Secures 1.5 Billion Yen in Series C Funding for Advancing Protein-Protein Interaction Technologies

PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein int...

 January 25, 2024 | News

Vaxart Gets $9.27M BARDA Award for Phase 2b COVID-19 Oral Pill Study

“We are very honored to receive this BARDA award, which will support the innovative approach of our oral pill vaccine platform,” said Dr. Micha...

 January 22, 2024 | News

Bora Pharmaceuticals Expands Globally with $210 Million Acquisition of Upsher-Smith

BioPharma APAC Perspective: Bora's acquisition of Upsher-Smith for $210 million marks a pivotal moment for the pharmaceutical giant. This strategic move n...

 January 18, 2024 | News

Rune Labs Secures $12M to Advance Adoption of Innovative Parkinson's Technologies.

Brings Total Raised to Over $42 Million Co-Founder of Nexus NeuroTech and Former Verily President of Medical Devices Jordi Parramon Joins as New Boar...

 January 12, 2024 | News

Clarametyx Biosciences Secures $33M in Series A Funding for Anti-Biofilm Biologics Development

Clarametyx Biosciences Inc. (“Clarametyx”), a clinical stage company developing targeted, immune-enabling biologic therapies to counter persist...

 January 08, 2024 | News

AstraZeneca Acquires Gracell, Expanding Cell Therapy Goals in Oncology and Autoimmune Diseases.

AstraZeneca has entered into a definitive agreement to acquire Gracell Biotechnologies Inc. (Gracell, NASDAQ: GRCL), a global clinical-stage biopharmaceuti...

 December 28, 2023 | News

Bristol Myers Squibb Acquires Karuna Therapeutics for $14 Billion

KarXT Is a Potential First-in-Class Treatment for Schizophrenia and as an Adjunctive Therapy, and First-in-Disease Treatment for Alzheimer’s Di...

 December 26, 2023 | News

LTS Secures $4.3M Grant for Contraceptive Microneedle Array Patch Development

Poor access to contraceptives presents a significant burden for women living in LMICs. According to a 2022 study, one in 14 women worldwide who want to use...

 December 20, 2023 | News

Biorithm Raises $3.5M in Series A to Advance Global Maternal Care

Biorithm, a global women's health medtech, has closed $3.5 million in Series A funding, co-led by Adaptive Capital Partners and SEEDS Capital. Wi...

 December 19, 2023 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close